Nano-designed CO donor ameliorates bleomycin-induced pulmonary fibrosis via macrophage manipulation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nano-designed CO donor ameliorates bleomycin-induced pulmonary fibrosis via macrophage manipulation

Published:2022-01 Issue: Volume:341 Page:566-577
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Guo Chunyu,Zhang Cheng,Xia Zhengmei,Song Bingdong,Hu Weirong,Cui Yingying,Xue Yanni,Xia Mizhen,Xu Dexiang,Zhang Shichen,Fang Jun

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference48 articles.

1. The role of natural products in the prevention and treatment of pulmonary fibrosis: a review;Wang;Food Funct.,2021

2. Idiopathic pulmonary fibrosis;Martinez;Nat. Rev. Dis. Primers,2017

3. Idiopathic pulmonary fibrosis;Richeldi;Lancet,2017

4. Immune mechanisms in pulmonary fibrosis;Kolahian;Am. J. Respir. Cell Mol. Biol.,2016

5. Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis;Kwapiszewska;Eur. Respir. J.,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carbon monoxide attenuates cellular senescence-mediated pulmonary fibrosis via modulating p53/PAI-1 pathway;European Journal of Pharmacology;2024-10

2. Self-assembled carbon monoxide nanogenerators managing sepsis through scavenging multiple inflammatory mediators;Bioactive Materials;2024-09

3. Ginsenoside Rh4 alleviates idiopathic pulmonary fibrosis by enhancing the CXCL9–CXCR3 axis;Food Frontiers;2024-03-25

4. Inhibitor of PD-1/PD-L1: a new approach may be beneficial for the treatment of idiopathic pulmonary fibrosis;Journal of Translational Medicine;2024-01-23

5. Elamipretide(SS-31) Attenuates Idiopathic Pulmonary Fibrosis by Inhibiting the Nrf2-Dependent NLRP3 Inflammasome in Macrophages;Antioxidants;2023-11-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3